Learn more

CENTRE NAT DE LA RECH SCIENT (CNRS)

Overview
  • Total Patents
    154
  • GoodIP Patent Rank
    15,287
  • Filing trend
    ⇩ 100.0%
About

CENTRE NAT DE LA RECH SCIENT (CNRS) has a total of 154 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2004. It filed its patents most often in United States, Canada and France. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are UNIV TOKYO, UNIV ALBERTA and MAX PLANCK GES ZUR FÖRDERUNG DER WISSENSCHAFTEN E V.

Patent filings per year

Chart showing CENTRE NAT DE LA RECH SCIENT (CNRS)s patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Bienvenu Frederic 4
#2 Vauzeilles Boris 4
#3 Ding Fang-Yuan 4
#4 Ferey Gerard 4
#5 Dukan Sam 4
#6 Herault Olivier 4
#7 Lacoste Ana 4
#8 Perez Emile 3
#9 Boucherle Benjamin 3
#10 Croquette Vincent 3

Latest patents

Publication Filing date Title
WO2017121755A1 Zuclopenthixol hydrochloride derivatives and ebselen derivatives as erbb2 inhibitors
WO2017077070A1 Complexes between block polymers and ions as contrast agents for medical imaging
WO2017037142A1 Foldamer helix bundle-based molecular encapsulation
WO2017017221A1 Vaccine composition against chlamydiaceae infections
WO2016198483A1 Tsm biosensor to ex-vivo characterize the viscoelastic properties of skin
WO2016156160A1 Frequency-tunable laser source and method for emitting a tunable laser beam
FR3043095A1 Sf6 gas electro-reduction process and reactor
US2017298351A1 Method For Screening Interfering Molecules
CA2960910A1 Nitrogen-containing analogs of salinomycin, synthesis and use against cancer stem cells and malaria
FR3038985A1 Method of quantifying proteins
FR3038986A1 Method of prognosis of pathologies
FR3038983A1 COMPOUNDS INHIBITING PSEUDOMONAS AERUGINOSA
FR3038734A1 New functionalized optical materials
FR3034106A1 MONOPHASIC ALLOY OF GOLD AND TUNGSTEN
FR3033173A1 Functionalization of lignocellulosic fibers by thiolene by photochemical pathway
US2016333022A1 Water soluble 4-azapodophyllotoxin analogs
US2015133363A1 GLUT-1 as a receptor for HTLV envelopes and its uses
FR3029210A1 METHOD OF PROGNOSIS OF HEMOPATHIES
FR3029014A1 Power transistor with vertical structure and trench cathode
FR3022244A1 Use of a new 3-aryl-4-catechol-pyrrole-n-propanol compound and derivatives thereof for the treatment of cancer and pathologies associated with excessive angiogenesis